Sort
50,496 grants matching “lung cancer”
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
$953,880William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Inpatient Technology-Supported Assisted Referral
$953,489Jeffrey L Fellows · Kaiser Foundation Research Institute · U01 · FY2010 · HL
Novel approaches to improve prediction of cancer-associated thrombosis
$953,390Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2019 · HL
Integrated, Individualized, Intelligent Prescribing (I3P)
$953,342Joshua C. Denny · Vanderbilt University · U01 · FY2015 · HG
New Paradigms for Targeting Truncal Driver Mutations
$953,025William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2019 · CA
Impact of Hearing Loss and Tinnitus in Cancer Survivors
$952,927Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2020 · CA
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
$952,822Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Multi-cancer early detection using cell-free DNA methylome analysis
$952,611Xianghong Jasmine Zhou · University Of California Los Angeles · U01 · FY2023 · CA
Immunohistochemistry Core Laboratory
$952,585Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Southern Community Cohort Study
$952,483William J. Blot · Vanderbilt University Medical Center · R01 · FY2015 · CA
Pulsed EPR Spectrometer
$952,390Timothy A Springer · Immune Disease Institute, Inc. · S10 · FY2008 · RR
Epidemiology of the four most frequent cancers following breast cancer
$952,389Kathleen E Malone · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
$952,264William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor
$952,237Hua Zhao · University Of Virginia · U01 · FY2025 · CA
GENERAL CLINICAL RESEARCH CENTER
$951,937Medical University Of South Carolina · M01 · FY2000 · RR
Preclinical development of TIMP-2 as a biologic therapy for cancer
$951,648William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Studying factors controlling cancer progression and immune recognition in mouse models
$951,640Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2025 · CA
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$951,608Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2021 · CA
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2020 · CA
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2018 · CA
National Lung Screening Trial (NLST)
$950,956Washington University · N01 · FY2009 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$950,923Mary Christine Playdon · University Of Utah · U01 · FY2023 · CA
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
$950,808Harold H Koeffler · University Of California Los Angeles · U54 · FY2010 · CA
Comparative Biomedical Scientist Training Program
$950,585Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2010 · CA